Windlas Biotech Limited IPO (WINDLAS)
Facts are NSE's own public-issue disclosures, refreshed periodically. Not investment advice; BrokerLens does not publish grey market premium (GMP) or recommend any IPO.
Brokerage-free equity & mutual fund investments
Trade with Zerodha's Kite platform and tools.
- Zero brokerage on equity delivery
- ₹20 flat for intraday, F&O, currency and commodity*
- Free direct mutual fund investing
Flat ₹20 per order, every segment
Trade stocks, derivatives and more on 5paisa's platform.
- ₹20 flat for delivery, intraday and F&O
- Free account opening
- Listed on NSE and BSE
Frequently asked questions
What is the price band for the Windlas Biotech Limited IPO?
The Windlas Biotech Limited IPO price band is Rs.448 to Rs.460 per share.
When does the Windlas Biotech Limited IPO open and close?
Bidding opens 4 August 2021 and closes 6 August 2021.
Is the Windlas Biotech Limited IPO a mainboard or SME issue?
Windlas Biotech Limited is a mainboard IPO, listing on NSE's main board.
When did the Windlas Biotech Limited IPO list?
Windlas Biotech Limited listed on 16 August 2021.
Does this page show the grey market premium (GMP) for Windlas Biotech Limited?
No. GMP is an unregulated, off-exchange estimate BrokerLens does not publish - see methodology. This page shows only NSE's own disclosed facts and, once bidding opens, NSE's own published subscription figures.
Is investing in the Windlas Biotech Limited IPO recommended by BrokerLens?
No. BrokerLens does not recommend any IPO, stock or broker. This page states public facts only; it is not investment advice.